Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 Study of KR25102 in Healthy Adult Chinese Participants
NCT07618156Phase 1Not yet recruiting
- Sponsor
- Jiangxi Kvvit Pharmaceutical
- Start
- Jun 2026
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in pain comparing Investigational Product (KR25102 for Injection) with Placebo (2 arms). Primary endpoint: Incidence and Severity of Adverse Events. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
KR25102
03
Conditions
pain
Beyond the preview
Go deeper on NCT07618156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07618156.